Discovery

Pillar objectives Pillar 1 focuses on discovering and formulating vaccines and monoclonal antibodies (H-mAbs) to prevent and treat infectious diseases with pandemic potential and aims to develop vaccines ready for large-scale deployment. WP4 Vaccine technology platforms (Lead: FBS; Partners involved: IP, ZEPAI, TiHO) Optimise RNA platform and advance a central RNA analytical laboratory to develop and [...]